Sale!

PML/RARA Quantitative Single Form Test

Original price was: $210.Current price is: $158.

-25%

The PML/RARA Quantitative Single Form test is a specialized genetic diagnostic tool that detects and quantifies the specific PML-RARA fusion gene associated with acute promyelocytic leukemia (APL). Using advanced Real-Time PCR technology, this test provides precise measurement of the genetic abnormality that drives this aggressive form of cancer. The test is essential for patients with suspected APL, those undergoing treatment monitoring, and individuals requiring disease progression assessment. Results are available within 2-3 days from bone marrow or peripheral blood samples. This comprehensive testing helps guide targeted therapy decisions and monitor treatment effectiveness. The test is available for $158 USD (discounted from $210 USD) and requires a doctor’s prescription for most cases.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

PML/RARA Quantitative Single Form Test – Advanced Genetic Cancer Detection

Understanding the PML/RARA Quantitative Single Form Test

The PML/RARA Quantitative Single Form test represents a breakthrough in genetic oncology diagnostics, specifically designed to detect and quantify the PML-RARA fusion gene that characterizes acute promyelocytic leukemia (APL). This sophisticated molecular test utilizes Real-Time PCR technology to provide precise measurements of this critical genetic abnormality, enabling healthcare providers to make informed decisions about treatment strategies and disease management.

What Does the Test Measure?

This specialized test specifically targets and quantifies the single form of the PML-RARA fusion gene, which results from a specific chromosomal translocation between chromosomes 15 and 17. The test measures:

  • Presence of the PML-RARA fusion gene
  • Quantitative levels of the genetic abnormality
  • Molecular response to treatment
  • Minimal residual disease detection

Who Should Consider This Test?

The PML/RARA Quantitative Single Form test is recommended for individuals experiencing symptoms or clinical indications of acute promyelocytic leukemia, including:

  • Patients with unexplained bleeding or bruising tendencies
  • Individuals experiencing persistent fatigue and weakness
  • Those with recurrent infections or fever of unknown origin
  • Patients showing abnormal blood cell counts
  • Individuals with suspected APL based on clinical presentation
  • Patients undergoing APL treatment requiring monitoring
  • Individuals with family history of hematological malignancies

Clinical Benefits of PML/RARA Testing

Choosing the PML/RARA Quantitative Single Form test provides numerous clinical advantages:

  • Early Detection: Identifies APL at molecular levels before full clinical manifestation
  • Treatment Guidance: Helps determine appropriate targeted therapy approaches
  • Monitoring Effectiveness: Tracks response to all-trans retinoic acid (ATRA) therapy
  • Prognostic Information: Provides valuable data for predicting disease outcomes
  • Minimal Residual Disease Detection: Identifies low levels of disease not detectable by conventional methods

Understanding Your Test Results

Your PML/RARA Quantitative Single Form test results will provide critical information about your genetic status:

  • Positive Result: Indicates presence of the PML-RARA fusion gene, confirming APL diagnosis
  • Quantitative Levels: Higher levels may indicate more aggressive disease or treatment resistance
  • Decreasing Levels: Suggests positive response to treatment
  • Undetectable Levels: May indicate complete molecular remission
  • Persistent Detection: Could suggest treatment resistance or impending relapse

Always discuss your results with your healthcare provider for proper interpretation and treatment planning.

Test Information and Pricing

Test Parameter Details
Test Name PML/RARA Quantitative Single Form
Regular Price $210 USD
Discount Price $158 USD
Turnaround Time 2-3 Days
Sample Type Bone Marrow / Peripheral Blood (Transport Immediately)
Test Components EDTA Vacutainer (4ml)
Testing Method Real Time PCR

Pre-Test Instructions

The PML/RARA Quantitative Single Form test requires a doctor’s prescription for most cases. Prescription requirements do not apply for surgery and pregnancy cases or individuals planning international travel. Our trained phlebotomists will collect your sample using proper sterile techniques to ensure accurate results.

Nationwide Testing Availability

GGC DNA provides comprehensive genetic testing services across all major cities in the United States. Our state-of-the-art laboratories and certified testing facilities ensure consistent, reliable results regardless of your location. We maintain branches in key metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose.

Take Control of Your Health Today

Don’t wait to get the critical genetic information you need for proper diagnosis and treatment planning. The PML/RARA Quantitative Single Form test provides essential data that can significantly impact your treatment journey and overall outcomes.

Ready to schedule your test? Call or WhatsApp us today at +1(267) 388-9828 to book your appointment or get more information about our genetic testing services.

Our knowledgeable staff is available to answer your questions, help you understand the testing process, and guide you through scheduling at one of our convenient locations across the United States.